– UK, Manchester – Yourgene Health PLC (LON: YGEN), a leading international molecular diagnostic group, today announced the appointment of Andy Leeser to to its Board as a Non-executive Director with immediate effect.
“I am delighted to welcome Andy to the Yourgene Board. I’m sure his breadth of experience will bring new perspectives and make a significant contribution to the future success of the Company.” said Board Chairman, Dr. John Brown CBE.
About Andrew Leeser
Andy Leeser is one of the UK’s most experienced mid-market corporate transformation specialists. He has been involved with a range of transformation projects and transactions, including refinancings and equity/ asset sales across the Automotive, Oil, and Gas, Brewing, Retail and Telecommunications sectors. Recent examples of businesses he has supported include Sepura plc, Sterling Resources, and OEG Offshore (Northstar Holding Ltd). He was also part of the team which, in cooperation with HMG, closed the English deep mine coal industry in a controlled manner. Andy is the current Chairman of the Institute for Turnaround.
About Yourgene Health
Yourgene Health is an international molecular diagnostics group which develops integrated genomic technologies and services enabling precision medicine. The group works in partnership with global leaders in DNA technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercializes simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine, and now infectious diseases. The Group’s flagship products include non-invasive prenatal tests for Down’s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.
The launch of Yourgene Genomic Services has enabled Yourgene to offer a global laboratory service network equipped to be a full life-cycle partner for clinical, research, and pharmaceutical organizations to support partners at the preclinical, clinical, and post-market stages to develop, manufacture, obtain regulatory approval and commercialize new products and services. In addition, Yourgene Genomic Services offers a NIPT and high throughput COVID testing service.
In August 2020, Yourgene acquired Coastal Genomics, Inc., a sample preparation technology company based in Vancouver, Canada, enabling the Company to extend its offering and IP portfolio in the DNA sample preparation sector. The acquisition increased Yourgene’s geographical penetration into the US and Canada, supplementing existing coverage in the UK, Europe, MEA, and Asia.
Yourgene Health is headquartered in Manchester, UK with offices in Taipei, Singapore, the US, and Canada, and is listed on the London Stock Exchange’s AIM market under the ticker “YGEN”.
For more information: https://www.yourgene-health.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.